Supporting Acute Myeloid Leukemia Research with Patient Samples
Core 2: Biospecimen
This core helps researchers understand acute myeloid leukemia (AML) better by collecting and managing patient samples and developing models that mimic human disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11124237 on NIH RePORTER |
What this research studies
This core is dedicated to advancing our understanding of acute myeloid leukemia (AML) by providing researchers with access to valuable patient samples. We carefully collect, organize, and track biospecimens from AML patients who participate in banking and treatment studies. This detailed information, including patient history and pathology findings, helps scientists create accurate models of AML. These models are then used to test new treatments in a "mouse hospital" setting, aiming to find more effective therapies for patients.
Who could benefit from this research
Good fit: Patients with acute myeloid leukemia who are enrolled in biospecimen banking or therapeutic research protocols may contribute samples to this core.
Not a fit: Patients not involved in specific AML biospecimen banking or therapeutic research protocols would not directly benefit from this core's activities.
Why it matters
Potential benefit: If successful, this core's work could accelerate the discovery and development of new, more effective treatments for acute myeloid leukemia by providing essential resources for researchers.
How similar studies have performed: Biospecimen cores are a well-established and essential component of successful translational research, providing critical resources for many disease areas.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: De Stanchina, Elisa — Sloan-Kettering Inst Can Research
- Study coordinator: De Stanchina, Elisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.